Loading...
ProMIS Neurosciences, Inc.
PMN•NASDAQ
Healthcare
Biotechnology
$0.82
$-0.30(-26.79%)
ProMIS Neurosciences, Inc. (PMN) Financial Performance & Statements
Review ProMIS Neurosciences, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.00%
Operating Income Growth
-88945.14%
↓ 88945.14%
Net Income Growth
15973.70%
↑ 15973.70%
Operating Cash Flow Growth
-89.19%
↓ 89.19%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-12.07%
↓ 12.07%
ROIC
-214.91%
↓ 214.91%
ProMIS Neurosciences, Inc. (PMN) Financial Statements
Explore quarterly and annual reports for ProMIS Neurosciences, Inc. stock.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
Gross Profit Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
R&D Expenses | $4.32M | $2.56M | $1.63M | $2.12M |
SG&A Expenses | $1.68M | $1.87M | $1.09M | $1.55M |
Operating Expenses | $6.002M | $4.43M | $2.71M | $3.68M |
Total Costs & Expenses | $6.002M | $4.43M | $2.71M | $3.68M |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $0.00 | $0.00 | $0.00 | $76775.00 |
Depreciation & Amortization | $0.00 | $13.71M | $90047.00 | $7166.00 |
EBITDA | -$238207.00 | $9.28M | -$2.62M | -$3.68M |
EBITDA Ratio | ||||
Operating Income | -$6.002M | -$4.43M | -$2.71M | -$3.68M |
Operating Income Ratio | ||||
Other Income/Expenses (Net) | $5.76M | $13.71M | $90049.00 | $41563.00 |
Income Before Tax | -$238207.00 | $9.28M | -$2.62M | -$3.64M |
Income Before Tax Ratio | ||||
Income Tax Expense | $0.00 | $0.00 | $0.00 | -$7167.00 |
Net Income | -$238207.00 | $9.28M | -$2.62M | -$3.64M |
Net Income Ratio | ||||
EPS | -$0.00 | $0.31 | -$0.13 | -$0.19 |
Diluted EPS | -$0.00 | $0.31 | -$0.13 | -$0.19 |
Weighted Avg Shares Outstanding | $25.92M | $30.02M | $19.77M | $19.53M |
Weighted Avg Shares Outstanding (Diluted) | $26.46M | $30.07M | $19.77M | $19.53M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan